Omni Agent Solutions Appoints Mike Hume Chief Technology Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation.

WOODLAND HILLS, Calif., Dec. 2, 2020 /PRNewswire/ — Omni Agent Solutions, an affiliate of Beilinson Advisory Group, today announced the appointment of Mike Hume as its new Chief Technology Officer (CTO). As CTO, Mr. Hume will oversee the company’s overall technology strategy, including the ongoing development and innovation of both its technology infrastructure and platforms.

“2020 has been a year of extraordinary growth and we are excited for someone with Mike’s expertise and industry experience to join our leadership team,” said Marc Beilinson, Chairman of Beilinson Advisory Group. “Mike will be instrumental in designing and executing our vision of innovative technology solutions, enhancing our cloud-based assets and growing our IT and software development department.”

With more than 25 years of technology experience, Mike spent 21 years at Computershare, a global

Read More

New study could help predict which individuals are more susceptible to cancer-causing agent — ScienceDaily

New insights into the mechanisms behind how cancer-causing agents in the environment activate genetic recombination in DNA could help to explain some of the effects of exposure as well as predicting which individuals may be more susceptible to developing the disease, a new UK study has suggested.

Everyone is exposed to low levels of carcinogens (substances or radiation that promote the formation of cancer) in the environment. One of the most widely found is benzopyrene — a general chemical pollutant found in smoke from stoves such as wood burners, exhaust fumes and barbequed meat and fish. One active ingredient of benzopyrene, BPDE, directly damages the DNA sequence forming what is known as adducts which in turn promote cancer-causing mutations.

While models exist showing how BPDE causes these mutations, some of the pathways are still not understood. It is currently believed that a BPDE adducts cause mutations during DNA synthesis because

Read More

Styra Expands Declarative Authorization Service with Free and Mid-tier Offerings to Manage Open Policy Agent at Scale

New Styra DAS Free and Pro editions simplify on-ramp for teams of all sizes to harness the power of Open Policy Agent for Kubernetes admission control in just minutes

Press release highlights:

  • Styra announces new editions of DAS, including free edition

  • Expands the ability to use OPA for Kubernetes admission control to teams of any size or budget and enables a completely self-service experience

  • Speeds OPA implementation and eliminates the need for learning and custom coding OPA policies for Kubernetes admission control

KubeCon | CloudNativeCon North America 2020 — Styra, Inc., the founders of Open Policy Agent (OPA) and leaders in cloud-native authorization, today announced a new three-tier product offering for Styra Declarative Authorization Service (DAS). The new DAS Free and DAS Pro editions, along with the existing DAS Enterprise, give teams of any size and stage a budget-friendly and fast option to operationalize OPA at scale for Kubernetes. Platform

Read More

Five9 to Acquire Inference Solutions, the Market Leading Intelligent Virtual Agent Platform

Accelerates the Five9 Artificial Intelligence portfolio by providing ‘digital workers’ that drive a new level of self service in the contact center

Expands the Five9 global footprint and Service Provider channel relationships

Five9, Inc. (NASDAQ: FIVN), a leading provider of the intelligent cloud contact center, today announced the execution of a definitive agreement to acquire Inference Solutions, the most widely deployed Intelligent Virtual Agent (IVA) platform.

“Intelligent and personalized self-service has become the preferred approach to service for customers,” said Donna Fluss, President, DMG Consulting, LLC. “IVAs, which are AI-enabled omni-channel self-service solutions, are going to play a major role in the future of customer service as they provide an outstanding service experience, while automating activities that previously required the attention of live agents. The acquisition of Inference by Five9 gives them a leading IVA solution, greatly expanding their self-service offerings.”

As a result of the global pandemic, customers are

Read More

Agent shows promising results in nonhuman primates — ScienceDaily

Researchers have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain injury. The team, led by investigators at Massachusetts General Hospital (MGH), recently received clearance from the U.S. Food and Drug Administration (FDA) to initiate a first-in-human study with the strategy.

As described in the Journal of Cerebral Blood Flow & Metabolism, the novel tracer, called [18F]3F4AP, is designed to bind to potassium channels and is radiolabeled so it can be visualized through positron emission tomography (PET) imaging. Potassium channels in the brain’s neurons become exposed when the neurons become demyelinated, or lose their protective coating (called myelin), which occurs with a variety of neurodegenerative conditions.

“Because potassium channels increase in expression and accessibility upon demyelination, this tracer holds promise for imaging multiple sclerosis and other diseases such as traumatic brain and spinal cord injuries, stroke and Alzheimer’s

Read More